Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction
US8071287B2 · kind B2 · utility
0Cited by
1References
2Claims
0Family size
Inventor
Key dates
| Filing date | Apr 24, 2006 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Feb 26, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprising an expression product of a Type Nine adenylyl cyclase gene polymorphism, along with a suitable physiological carrier, are provided. In addition, methods related to treating patients having asthma or a reversible bronchial obstruction, kits for determining the responsiveness of an individual to treatment regimens, and assays for screening pharmaceutical for efficacy in treatment are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.